Please try another search
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Todd C. Davis | 63 | 2023 | Independent Chairman of the Board |
Stephen G. Waxman | - | - | Chair of Scientific Advisory Board |
Chia-Lin Simmons | 51 | 2023 | Independent Director |
Ezra Friedberg | 54 | 2021 | Independent Director |
Richard Malamut | 64 | 2023 | Independent Director |
Robert H. Dworkin | - | - | Chair of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review